FAST: towards safe and effective subcutaneous immunotherapy of persistent life-threatening food allergies

@inproceedings{ZuidmeerJongejan2012FASTTS,
  title={FAST: towards safe and effective subcutaneous immunotherapy of persistent life-threatening food allergies},
  author={Laurian Zuidmeer-Jongejan and Montserrat Fern{\'a}ndez-Rivas and Lars K{\ae}rgaard Poulsen and Angela Neubauer and Juan Andr{\'e}s Asturias and L H Blom and Joyce Irene Boye and Carsten Bindslev-Jensen and Michael Clausen and Rosa Ferrara and Paula Garosi and Hans Joachim Roewert Huber and Bettina M Jensen and Stef J Koppelman and Marek L Kowalski and Anna Lewandowska-Polak and Birgit Linhart and Bernard Maillere and Adriano Mari and Alberto Martinez and Clare Mills and Claudio Nicoletti and D. J. E. Opstelten and Nikolaos G. Papadopoulos and Antonio Portol{\'e}s and Neil Marcus Rigby and E Scala and Heidi Julius Schnoor and S T Sigurdardottir and George A. Stavroulakis and Frank Stolz and I Swoboda and Rudolf Valenta and Rob van den Hout and Serge A. Versteeg and Marianne Witten and Ronald van Ree},
  booktitle={Clinical and translational allergy},
  year={2012}
}
The FAST project (Food Allergy Specific Immunotherapy) aims at the development of safe and effective treatment of food allergies, targeting prevalent, persistent and severe allergy to fish and peach. Classical allergen-specific immunotherapy (SIT), using subcutaneous injections with aqueous food extracts may be effective but has proven to be accompanied by too many anaphylactic side-effects. FAST aims to develop a safe alternative by replacing food extracts with hypoallergenic recombinant major… CONTINUE READING